Our highest priority project is funding clinical trials of 3,4-methylenedioxymethamphetamine (MDMA) as a tool to assist therapy for the treatme

Support Psychedelic Science to Help Change Lives

submited by
Style Pass
2021-06-15 01:30:03

Our highest priority project is funding clinical trials of 3,4-methylenedioxymethamphetamine (MDMA) as a tool to assist therapy for the treatment of posttraumatic stress disorder (PTSD).

We have also sponsored clinical trials of MDMA-assisted therapy for anxiety associated with life-threatening illness and social anxiety in autistic adults, LSD-assisted therapy for anxiety, and medical marijuana for PTSD in veterans of war. We have sponsored observational studies for ibogaine therapy for drug addiction and ayahuasca-assisted treatment for drug addiction and PTSD.

In addition to our clinical research programs, MAPS provides harm reduction training and services through the Zendo Project , advocates for reducing barriers to scientific research with psychedelics and marijuana, and curates educational events and webinars.

We are a 501(c)(3) non-profit research and educational organization developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

Leave a Comment